ES2185769T3 - Oxidos de polietileno con un resto sacarido en un extremo y un grupo funcional diferente en el otro extremo y procedimientos de produccion de los mismos. - Google Patents
Oxidos de polietileno con un resto sacarido en un extremo y un grupo funcional diferente en el otro extremo y procedimientos de produccion de los mismos.Info
- Publication number
- ES2185769T3 ES2185769T3 ES96909364T ES96909364T ES2185769T3 ES 2185769 T3 ES2185769 T3 ES 2185769T3 ES 96909364 T ES96909364 T ES 96909364T ES 96909364 T ES96909364 T ES 96909364T ES 2185769 T3 ES2185769 T3 ES 2185769T3
- Authority
- ES
- Spain
- Prior art keywords
- denote
- rest
- functional group
- oligomero
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 2
- -1 POLYETHYLENE Polymers 0.000 title 1
- 239000004698 Polyethylene Substances 0.000 title 1
- 229920000573 polyethylene Polymers 0.000 title 1
- 229920000642 polymer Polymers 0.000 abstract 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229920000728 polyester Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/66—Polyesters containing oxygen in the form of ether groups
- C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
- C08G65/2603—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
- C08G65/2606—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen containing hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
Abstract
LA INVENCION DESCRIBE UN OLIGOMERO O POLIMERO HETEROTELEQUELICO QUE ESTA REPRESENTADO POR LA FORMULA INDICADA, EN LA CUAL A DENOTA UN RESTO SACARIDO, L DENOTA UN GRUPO DE ENLACE REPRESENTADO POR LA FORMULA INDICADA O ( - CH 2 ) 4 , EN LA CUAL R 1 Y R 2 DENOTAN INDEPENDIENTEMENTE ALQUILO, ARALQUILO O ARILO INFERIOR, X DENOTA UN ENLACE SENCILLO O - CH 2 CH 2 - , Z DENOTA UN GRUPO QUE FORMA UN ETER O ES TER INSATURADO, O UN GRUPO FUNCIONAL TAL COMO HALOGENO QUE SE UNE A - CH 2 CH 2 , N DENOTA UN NUMERO ENTERO DESDE 5 - 10.000, Y M DENOTA UN NUMERO ENTERO DESDE 0 O 2 - 10.000. ESTA INVENCION TAMBIEN DESCRIBE UN PROCEDIMIENTO PARA PRODUCIR EL ANTERIOR OLIGOMERO O POLIMERO, Y ADEMAS UNA MICELA DE ELEVADO PESO MOLECULAR CON EL USO DE UN POLIMERO EN BLOQUE DE POLI(OXIDO DE ETILENO) - POLIESTER QUE PRESENTA UN RESTO SACARIDO EN UN EXTREMO. SE ESPERA QUE DICHO OLIGOMERO O POLIMERO MUESTRA UNA EXCELENTE BIODISPONIBILIDAD Y TAMBIEN SE ESPERA QUE PUEDA UTILIZARSE EN EL CAMPO TAL COMO DE LOS VEHICULOS PARA LA ADMINISTRACION DE FARMACOS O REACTIVOS DE DIAGNOSTICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8937395 | 1995-04-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2185769T3 true ES2185769T3 (es) | 2003-05-01 |
Family
ID=13968897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96909364T Expired - Lifetime ES2185769T3 (es) | 1995-04-14 | 1996-04-12 | Oxidos de polietileno con un resto sacarido en un extremo y un grupo funcional diferente en el otro extremo y procedimientos de produccion de los mismos. |
Country Status (20)
Country | Link |
---|---|
US (2) | US5973069A (es) |
EP (1) | EP0852243B1 (es) |
JP (1) | JP4036472B2 (es) |
KR (1) | KR19990007804A (es) |
CN (1) | CN1085690C (es) |
AT (1) | ATE226966T1 (es) |
AU (1) | AU5289096A (es) |
BR (1) | BR9604895A (es) |
CA (1) | CA2218140A1 (es) |
DE (1) | DE69624581T2 (es) |
DK (1) | DK0852243T3 (es) |
ES (1) | ES2185769T3 (es) |
HU (1) | HU221090B1 (es) |
MX (1) | MX9707887A (es) |
NO (1) | NO974728L (es) |
NZ (1) | NZ304991A (es) |
PT (1) | PT852243E (es) |
RU (1) | RU2193574C2 (es) |
SI (1) | SI9620064A (es) |
WO (1) | WO1996032434A1 (es) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6133347A (en) * | 1999-07-09 | 2000-10-17 | Mbt Holding Ag | Oligomeric dispersant |
US6861459B2 (en) * | 1999-07-09 | 2005-03-01 | Construction Research & Technology Gmbh | Oligomeric dispersant |
US6908955B2 (en) * | 1999-07-09 | 2005-06-21 | Construction Research & Technology Gmbh | Oligomeric dispersant |
JP2001048978A (ja) | 1999-08-04 | 2001-02-20 | Nano Career Kk | オキサゾリン由来のポリマーセグメントを有するブロックコポリマー |
JP2001208754A (ja) * | 2000-01-26 | 2001-08-03 | Kazunori Kataoka | 生物学的な被検体を検出するための組成物 |
JP2001247591A (ja) * | 2000-03-02 | 2001-09-11 | Natl Inst Of Advanced Industrial Science & Technology Meti | 重合性グルコフラノース誘導体およびその製造方法 |
EP1279959A4 (en) * | 2000-05-11 | 2006-07-05 | Toudai Tlo Ltd | POLYMER COMPOSITION FOR FORMING THE SURFACE OF A BIOSENSOR |
JP4063510B2 (ja) * | 2001-07-13 | 2008-03-19 | ナノキャリア株式会社 | 薬物含有高分子ミセルの凍結乾燥用組成物およびその凍結乾燥製剤 |
CN1798832B (zh) | 2001-07-26 | 2010-04-28 | 片冈一则 | 含有动物培养细胞球状体的培养细胞构成物及其用途 |
WO2003018665A1 (en) | 2001-08-22 | 2003-03-06 | Bioartificial Gel Technologies Inc. | Process for the preparation of activated polyethylene glycols |
WO2003076933A1 (fr) * | 2002-03-11 | 2003-09-18 | Toudai Tlo, Ltd. | Surface en poly(ethylene oxyde) a structure de type pinceau presentant une densite elevee |
US20060127899A1 (en) * | 2002-05-08 | 2006-06-15 | Ralf Krahmer | Active carbohydrate containing protecting reagents for chemical modifications, their production and use |
JPWO2005073370A1 (ja) * | 2004-01-31 | 2008-01-10 | 株式会社トランスパレント | 酵素複合体 |
US7351787B2 (en) * | 2004-03-05 | 2008-04-01 | Bioartificial Gel Technologies, Inc. | Process for the preparation of activated polyethylene glycols |
EP1897900B1 (en) | 2005-06-09 | 2013-08-07 | NanoCarrier Co., Ltd. | Process for production of polymerized coordination compound of platinum complex |
JP5277439B2 (ja) | 2006-03-01 | 2013-08-28 | 国立大学法人 東京大学 | 核酸内包高分子ミセル複合体 |
KR20080106219A (ko) * | 2006-03-06 | 2008-12-04 | 나노캬리아 가부시키가이샤 | 소수성 화합물의 안정화제 |
EP2011516A4 (en) * | 2006-04-24 | 2010-06-23 | Nanocarrier Co Ltd | PROCESS FOR THE PRODUCTION OF A POLYMERIC MICELLE THAT CONTAINS A CHEMICAL PRODUCT OF LOW MOLECULAR WEIGHT ENCAPSULATED IN IT |
CN101489574A (zh) | 2006-07-18 | 2009-07-22 | 那野伽利阿株式会社 | 内包生理活性多肽或蛋白质的高分子聚合物胶束及其制造方法 |
EP2087912B1 (en) | 2006-11-22 | 2017-05-10 | The University of Tokyo | Sirna carrier using disulfide-bridged polymeric micelle |
US20080161535A1 (en) * | 2006-12-21 | 2008-07-03 | Wiggins Michael S | Thickening and wetting agents |
CN101952324B (zh) * | 2007-07-12 | 2014-08-13 | 巴斯夫欧洲公司 | 基于硝化纤维素的分散剂 |
US8075909B2 (en) | 2007-09-04 | 2011-12-13 | University Of Florida Research Foundation, Incorporated | Contact lens based bioactive agent delivery system |
EP2284210B1 (en) | 2008-04-30 | 2017-12-06 | The University of Tokyo | Charge conversional ternary polyplex |
AU2009263529B2 (en) | 2008-06-24 | 2013-09-26 | Nanocarrier Co., Ltd. | Liquid composition comprising cisplatin-coordinating compound |
JP5651468B2 (ja) | 2008-06-26 | 2015-01-14 | 独立行政法人科学技術振興機構 | Mri造影能を有する重合体−金属錯体複合体、並びにそれを用いたmri造影用及び/又は抗腫瘍用組成物 |
TW201120063A (en) * | 2009-08-21 | 2011-06-16 | Idemitsu Kosan Co | Sugar derivative having a polymerizable group, and resist material using said sugar derivative |
WO2011043980A1 (en) | 2009-10-07 | 2011-04-14 | Sanford Burnham Medical Research Institute | Methods and compositions related to clot-binding lipid compounds |
JP4829351B2 (ja) | 2010-02-05 | 2011-12-07 | ナノキャリア株式会社 | 易崩壊型ポリマーミセル組成物 |
EP2555802A1 (en) | 2010-04-08 | 2013-02-13 | Sanford-Burnham Medical Research Institute | Methods and compositions for enhanced delivery of compounds |
JP5843763B2 (ja) | 2010-05-21 | 2016-01-13 | 国立研究開発法人科学技術振興機構 | 物質内包ベシクル及びその製造方法 |
WO2012005376A1 (ja) | 2010-07-09 | 2012-01-12 | 国立大学法人 東京大学 | 核酸送達用組成物及び担体組成物、それを用いた医薬組成物、並びに核酸送達方法 |
WO2012118778A1 (en) | 2011-02-28 | 2012-09-07 | Sanford-Burnham Medical Research Institute | Truncated car peptides and methods and compositions using truncated car peptides |
US10179801B2 (en) | 2011-08-26 | 2019-01-15 | Sanford-Burnham Medical Research Institute | Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides |
RU2538211C2 (ru) * | 2012-09-12 | 2015-01-10 | Федеральное государственное бюджетное учреждение науки Институт высокомолекулярных соединений Российской академии наук | Способ получения углеводсодержащих полимеров |
JP6049854B2 (ja) | 2013-03-01 | 2016-12-27 | 国立研究開発法人科学技術振興機構 | 物質内包ベシクル及びその製造方法 |
WO2014157150A1 (ja) * | 2013-03-25 | 2014-10-02 | 日油株式会社 | ベンジリデンアセタールリンカーを有する親水性ポリマー誘導体 |
CA2911495A1 (en) | 2013-05-17 | 2014-11-20 | Nanocarrier Co., Ltd. | Polymeric micelle pharmaceutical composition |
JP2015046867A (ja) | 2013-07-31 | 2015-03-12 | 株式会社リコー | 撮像装置 |
JP6108369B2 (ja) | 2013-08-06 | 2017-04-05 | 国立研究開発法人科学技術振興機構 | 核酸内包高分子ミセル複合体及びその製造方法 |
JP6145612B2 (ja) | 2013-08-23 | 2017-06-14 | 国立大学法人 東京大学 | 高分子ナノ粒子複合体、及びそれを含むmri造影用組成物 |
JP5971264B2 (ja) | 2014-01-10 | 2016-08-17 | Jfeスチール株式会社 | 極厚肉油井管用ねじ継手 |
WO2016210423A2 (en) | 2015-06-25 | 2016-12-29 | Sanford Burnham Prebys Medical Discovery Institute | Compositions for delivery to and treatment of atherosclerotic plaques |
DE102017003004A1 (de) * | 2017-03-23 | 2018-09-27 | Friedrich-Schiller-Universität Jena | Kationische Polymere mit D-Fructose-Substituenten |
US20200190142A1 (en) | 2017-05-02 | 2020-06-18 | Stanford Burnham Prebys Medical Discovery Institute | Tumor associated monocyte/macrophage binding peptide and methods of use thereof |
WO2020161602A1 (en) | 2019-02-04 | 2020-08-13 | University Of Tartu | Bi-specific extracellular matrix binding peptides and methods of use thereof |
EP3808757A1 (en) | 2019-10-14 | 2021-04-21 | École Polytechnique Fédérale de Lausanne (EPFL) | Renewable monomer and polymer thereof |
CN112029084B (zh) * | 2020-08-31 | 2021-10-26 | 华南理工大学 | 一种以硫代羧酸为引发剂简便、可控合成α-巯基-ω-羟基聚醚的方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3163056D1 (en) * | 1980-06-20 | 1984-05-17 | Goldschmidt Ag Th | Process for the production of polymers with at least one terminal primary hydroxyl group |
EP0154316B1 (en) * | 1984-03-06 | 1989-09-13 | Takeda Chemical Industries, Ltd. | Chemically modified lymphokine and production thereof |
GB8427886D0 (en) * | 1984-11-03 | 1984-12-12 | Manchester Inst Science Tech | Formation of polyols |
JPS61152393A (ja) * | 1984-12-26 | 1986-07-11 | 株式会社日立製作所 | 複合材の切断方法および切断金型 |
JPS63152393A (ja) * | 1986-07-03 | 1988-06-24 | Takeda Chem Ind Ltd | グリコシル誘導体 |
US5037969A (en) * | 1986-07-03 | 1991-08-06 | Takeda Chemical Industries, Ltd. | Glycosyl derivatives and use thereof |
JPH07103208B2 (ja) * | 1990-02-14 | 1995-11-08 | エルフ アトケム ソシエテ アノニム | 官能性多元ブロックマクロモノマーと、その製造方法 |
DE4039193A1 (de) * | 1990-12-08 | 1992-06-11 | Bayer Ag | In wasser dispergierbare, elektrolytstabile polyetherester-modifizierte polyurethanionomere |
WO1992004048A2 (en) * | 1990-08-30 | 1992-03-19 | The Biomembrane Institute | Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
US5410016A (en) * | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
JP2593032B2 (ja) * | 1992-02-07 | 1997-03-19 | 新技術事業団 | 両末端ヘテロ官能性ポリエーテル並びに該ポリエーテルを製造する方法及び重合開始剤 |
DE4313117C2 (de) * | 1993-04-22 | 1995-09-28 | Grillo Werke Ag | Fettsäureester von Methylglukosid-Derivaten, Verfahren zu ihrer Herstellung und Verwendung |
DE4317231A1 (de) * | 1993-05-24 | 1994-12-01 | Wolff Walsrode Ag | Thermoplastische Celluloseetherester-Mischpfropfpolymerisate und Verfahren zu ihrer Herstellung |
JP3465307B2 (ja) * | 1993-08-05 | 2003-11-10 | 日本油脂株式会社 | ポリアルキレンオキシド誘導体および製造方法 |
JP3407397B2 (ja) * | 1994-05-06 | 2003-05-19 | 日本油脂株式会社 | ポリオキシアルキレン誘導体および製造方法 |
JP3508207B2 (ja) * | 1994-05-30 | 2004-03-22 | 日本油脂株式会社 | ポリオキシアルキレン誘導体の製造方法 |
JP3508234B2 (ja) * | 1994-09-22 | 2004-03-22 | 日本油脂株式会社 | ポリオキシアルキレン誘導体の製造方法 |
-
1996
- 1996-04-12 DE DE69624581T patent/DE69624581T2/de not_active Expired - Lifetime
- 1996-04-12 KR KR1019970707327A patent/KR19990007804A/ko not_active Application Discontinuation
- 1996-04-12 WO PCT/JP1996/001020 patent/WO1996032434A1/ja not_active Application Discontinuation
- 1996-04-12 NZ NZ304991A patent/NZ304991A/en unknown
- 1996-04-12 US US08/930,855 patent/US5973069A/en not_active Expired - Lifetime
- 1996-04-12 CN CN96194581A patent/CN1085690C/zh not_active Expired - Lifetime
- 1996-04-12 HU HU9801120A patent/HU221090B1/hu not_active IP Right Cessation
- 1996-04-12 AU AU52890/96A patent/AU5289096A/en not_active Abandoned
- 1996-04-12 PT PT96909364T patent/PT852243E/pt unknown
- 1996-04-12 BR BR9604895-6A patent/BR9604895A/pt not_active Application Discontinuation
- 1996-04-12 MX MX9707887A patent/MX9707887A/es not_active IP Right Cessation
- 1996-04-12 AT AT96909364T patent/ATE226966T1/de not_active IP Right Cessation
- 1996-04-12 ES ES96909364T patent/ES2185769T3/es not_active Expired - Lifetime
- 1996-04-12 SI SI9620064A patent/SI9620064A/sl not_active IP Right Cessation
- 1996-04-12 JP JP53089296A patent/JP4036472B2/ja not_active Expired - Lifetime
- 1996-04-12 EP EP96909364A patent/EP0852243B1/en not_active Expired - Lifetime
- 1996-04-12 DK DK96909364T patent/DK0852243T3/da active
- 1996-04-12 CA CA002218140A patent/CA2218140A1/en not_active Abandoned
- 1996-04-12 RU RU97118657/04A patent/RU2193574C2/ru not_active IP Right Cessation
-
1997
- 1997-10-13 NO NO974728A patent/NO974728L/no not_active Application Discontinuation
-
1999
- 1999-07-27 US US09/361,958 patent/US6090317A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NO974728L (no) | 1997-12-05 |
HUP9801120A2 (hu) | 1998-08-28 |
NZ304991A (en) | 2000-02-28 |
PT852243E (pt) | 2003-03-31 |
HUP9801120A3 (en) | 1998-12-28 |
US6090317A (en) | 2000-07-18 |
US5973069A (en) | 1999-10-26 |
SI9620064A (sl) | 1998-06-30 |
KR19990007804A (ko) | 1999-01-25 |
CN1187212A (zh) | 1998-07-08 |
MX9707887A (es) | 1997-11-29 |
CN1085690C (zh) | 2002-05-29 |
RU2193574C2 (ru) | 2002-11-27 |
DK0852243T3 (da) | 2003-02-24 |
BR9604895A (pt) | 1999-11-30 |
DE69624581D1 (de) | 2002-12-05 |
EP0852243B1 (en) | 2002-10-30 |
AU5289096A (en) | 1996-10-30 |
CA2218140A1 (en) | 1996-10-17 |
NO974728D0 (no) | 1997-10-13 |
ATE226966T1 (de) | 2002-11-15 |
EP0852243A4 (en) | 1998-08-26 |
EP0852243A1 (en) | 1998-07-08 |
JP4036472B2 (ja) | 2008-01-23 |
WO1996032434A1 (fr) | 1996-10-17 |
HU221090B1 (en) | 2002-08-28 |
DE69624581T2 (de) | 2003-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2185769T3 (es) | Oxidos de polietileno con un resto sacarido en un extremo y un grupo funcional diferente en el otro extremo y procedimientos de produccion de los mismos. | |
Mayordomo | Contributions to the study of resource-bounded measure | |
DE69123795T3 (de) | Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau | |
ES2188787T3 (es) | Compuesto medicamentoso de micela copolimera y metodo para su preparacion. | |
DE60214173D1 (de) | Negativ geladenes amphiphiles blockcopolymer als arzneistoffträger und komplex davon mit postitiv geladenem arzneistoff | |
GR1000456B (el) | Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιλαμβανουν κυκλοσπορινες. | |
PT99108A (pt) | Processo de preparacao de uma composicao farmaceutica a base de portadores naoaquosos de perfluorocarbonetos ou silicone fluorado | |
ES2110377T1 (es) | Formulacion galenica de fenofibrato y aplicacion de la misma. | |
CO4560480A1 (es) | Espesadores asociativos | |
PT1318791E (pt) | Composicao farmaceutica semi-solida de isotretinoina | |
IL183296A0 (en) | Multivalent vaccine composition with mixed carrier | |
AR033859A1 (es) | Inhibidores de la metaloproteinasa de la matriz | |
DE60220519D1 (de) | Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe | |
DE602004018772D1 (de) | Pharmazeutische zusammensetzungen - ph-sensitive blockcopolymere und einen hydrophoben wirkstoff enthaltend | |
ES2058081T3 (es) | Poliesteres que contienen bloques de oxido de alquileno como sistemas de administracion de medicamentos. | |
CY1106257T1 (el) | ΧΡΗΣΗ ΠΑΡΑΓΩΓΩΝ ΠΥΡΙΔΑΖΙΝΟ [4,5-(b)]-ΙΝΔΟΛΗ -1-ΑΚΕΤΑΜΙΔΗ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΣΚΕΥΑΣΜΑΤΩΝ ΠΟΥ ΠΡΟΟΡΙΖΟΝΤΑΙ ΓΙΑ ΝΟΣΟΥΣ ΠΟΥ ΣΥΝΔΕΟΝΤΑΙ ΜΕ ΤΗ ΔΥΣΛΕΙΤΟΥΡΓΙΑ ΤΩΝ ΥΠΟΔΟΧΕΩΝ ΠEPΙΦEPΙΚΟΥ ΤΥΠΟΥ ΣΤΙΣ ΒΕΝΖΟΔΙΑΖΕΠΙΝΕΣ | |
DK1372729T3 (da) | Nedbrydelige polymere til injektion | |
ES2095840T3 (es) | Conjugado de anticuerpo-farmaco. | |
DE60220796D1 (de) | Positiv geladenes amphiphiles blockcopolymer als arzneistoffträger und komplex davon mit negativ geladenem arzneistoff | |
BR112016006287A2 (pt) | método de tratamento de uma formação subterrânea | |
AR030016A1 (es) | Derivados de 4-oxo-3,5-dihidro-4h-piridazino [4,5-b]indol-1-carboxamida, medicamento y composicion farmaceutica que comprenden a dichos derivados | |
DK1268522T3 (da) | LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler | |
ES2049938T3 (es) | Procedimiento de condensacion de al menos un epoxido sobre al menos un anhidrido ciclico en presencia de un catalizador a base de al menos un complejo nitrogenado de titanio. | |
EA200200370A1 (ru) | Препараты эстрамустинфосфата и сульфоалкиловых эфиров циклодекстринов для парентерального применения | |
PT1259515E (pt) | Derivados da tienopiridina e a sua utilizacao como agentes anti-inflamatorios |